Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach.

ABSTRACT: Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that has been responsible for numerous large-scale outbreaks in the last twenty years. Currently, there are no FDA-approved therapeutics for any alphavirus infection. CHIKV nonstructural protein 2 (nsP2), which contains a cysteine protease domain, is essential for viral replication, making it an attractive target for a drug discovery campaign. Here, we optimized a CHIKV nsP2 protease (nsP2pro) biochemical assay for the screening of a 6,120-compound cysteine-directed covalent fragment library. Using a 50% inhibition threshold, we identified 153 hits (2.5% hit rate). In dose-response follow-up, RA-0002034, a covalent fragment that contains a vinyl sulfone warhead, inhibited CHIKV nsP2pro with an IC₅₀ of 58 ± 17 nM, and furth

SUBMITTER: Merten EM 

PROVIDER: S-EPMC11494320 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature